A brief history of the randomized controlled trial. From oranges and lemons to the gold standard.

[1]  Steven Epstein,et al.  The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials , 1995, Science, technology & human values.

[2]  Mamounas Ep.  Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies. , 1998 .

[3]  Alvan R. Feinstein,et al.  Principles of Medical Statistics , 2001 .

[4]  J. Wyckoff,et al.  THE THERAPEUTIC VALUE OF DIGITALIS IN PNEUMONIA , 1930 .

[5]  R Doll,et al.  Controlled trials: the 1948 watershed , 1998, BMJ.

[6]  Arthur K. Shapiro,et al.  The Powerful Placebo: From Ancient Priest to Modern Physician , 1997 .

[7]  C. Meinert,et al.  A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. , 1970, Diabetes.

[8]  T. Sollmann.  THE EVALUATION OF THERAPEUTIC REMEDIES IN THE HOSPITAL , 1930 .

[9]  T. Greenhalgh.  “Is my practice evidence-based?” , 1996, BMJ.

[10]  A. Hrõbjartsson,et al.  The controlled clinical trial turns 100 years: Fibiger's trial of serum treatment of diphtheria , 1998, BMJ.

[11]  Robert C. Miller,et al.  Effect of corticosteroids on hypercalc˦mia of malignant disease , 1971 .

[12]  H. Marks.  10. Notes from the Underground: The Social Organization of Therapeutic Research , 1988 .

[13]  J. Snow.  On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.

[14]  J. Mckinlay.  From "promising report" to "standard procedure": seven stages in the career of a medical innovation. , 1981, The Milbank Memorial Fund quarterly. Health and society.

[15]  Lilienfeld Am,et al.  The Fielding H. Garrison Lecture: Ceteris paribus: the evolution of the clinical trial. , 1982, Bulletin of the history of medicine.

[16]  R. Miller,et al.  Propoxyphene hydrochloride. A critical review. , 1970, JAMA.

[17]  W. Modell,et al.  Factors influencing clinical evaluation of drugs; with special reference to the double-blind technique. , 1958, Journal of the American Medical Association.

[18]  A. Hill.  I.?THE AIM OF THE STATISTICAL METHOD , 1937 .

[19]  S. Epstein.  Activism, Drug Regulation, and the Politics of Therapeutic Evaluation in the AIDS Era: A Case Study of ddC and the `Surrogate Markers' Debate , 1997, Social studies of science.

[20]  B. Fisher.  National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Love.  The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  Alan Yoshioka.  Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940s , 1998, BMJ.

[23]  R. Maulitz,et al.  Grand Rounds: One Hundred Years of Internal Medicine , 1988 .

[24]  Ben Wolepor.  The "American Review of Tuberculosis". , 1929, Canadian Medical Association journal.

[25]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[26]  C. Redmond,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.

[27]  H. Beecher,et al.  The powerful placebo. , 1955, Journal of the American Medical Association.

[28]  F. Fergusson.  Propoxyphene and friends. , 1970, JAMA.

[29]  I. Chalmers.  The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care , 1993, Annals of the New York Academy of Sciences.

[30]  W. Taylor,et al.  A comparative evaluation of marketed analgesic drugs. , 1972, The New England journal of medicine.

[31]  A. Feinstein,et al.  Problems in the "evidence" of "evidence-based medicine". , 1997, The American journal of medicine.

[32]  A. Cornelius Benjamin,et al.  Science, Technology, and Human Values , 1966 .

[33]  H. Marks,et al.  Reviews: Medicine and Health-The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 , 1997 .

[34]  M. Meldrum.  “A calculated risk”: the Salk polio vaccine field trials of 1954 , 1998, BMJ.

[35]  E. Fee,et al.  Aids the Making of a Chronic Disease , 1992 .

[36]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[37]  A. Omran,et al.  The epidemiologic transition. A theory of the Epidemiology of population change. 1971. , 2001, Bulletin of the World Health Organization.

[38]  Gerald L. Geison.  The Private Science of Louis Pasteur , 1995 .